143 related articles for article (PubMed ID: 34247699)
1. N-Nitrosodimethylamine-Contaminated Valsartan and the Risk of Cancer—A Longitudinal Cohort Study Based on German Health Insurance Data.
Gomm W; Röthlein C; Schüssel K; Brückner G; Schröder H; Heß S; Frötschl R; Broich K; Haenisch B
Dtsch Arztebl Int; 2021 May; 118(21):357-362. PubMed ID: 34247699
[TBL] [Abstract][Full Text] [Related]
2. Use of N-nitrosodimethylamine (NDMA) contaminated valsartan products and risk of cancer: Danish nationwide cohort study.
Pottegård A; Kristensen KB; Ernst MT; Johansen NB; Quartarolo P; Hallas J
BMJ; 2018 Sep; 362():k3851. PubMed ID: 30209057
[TBL] [Abstract][Full Text] [Related]
3.
Mansouri I; Botton J; Semenzato L; Haddy N; Zureik M
J Am Heart Assoc; 2022 Dec; 11(24):e8067. PubMed ID: 36533625
[TBL] [Abstract][Full Text] [Related]
4. Short commentary on NDMA (N-nitrosodimethylamine) contamination of valsartan products.
Snodin DJ; Elder DP
Regul Toxicol Pharmacol; 2019 Apr; 103():325-329. PubMed ID: 30629969
[TBL] [Abstract][Full Text] [Related]
5. Analysis of an Impurity, N-Nitrosodimethylamine, in Valsartan Drug Substances and Associated Products Using GC-MS.
Tsutsumi T; Akiyama H; Demizu Y; Uchiyama N; Masada S; Tsuji G; Arai R; Abe Y; Hakamatsuka T; Izutsu KI; Goda Y; Okuda H
Biol Pharm Bull; 2019 Apr; 42(4):547-551. PubMed ID: 30726781
[TBL] [Abstract][Full Text] [Related]
6. Rapid and efficient high-performance liquid chromatography analysis of N-nitrosodimethylamine impurity in valsartan drug substance and its products.
Masada S; Tsuji G; Arai R; Uchiyama N; Demizu Y; Tsutsumi T; Abe Y; Akiyama H; Hakamatsuka T; Izutsu KI; Goda Y; Okuda H
Sci Rep; 2019 Aug; 9(1):11852. PubMed ID: 31413326
[TBL] [Abstract][Full Text] [Related]
7. Understanding and Preventing (
White CM
Ann Pharmacother; 2020 Jun; 54(6):611-614. PubMed ID: 31771343
[No Abstract] [Full Text] [Related]
8. Cancer risk from nitrosamine-contaminated valsartan.
Drug Ther Bull; 2021 Oct; 59(10):147. PubMed ID: 34301726
[No Abstract] [Full Text] [Related]
9. Pharmacists are key in interpreting clinical implications of N-nitrosodimethylamine contamination in medications.
Eads AV
J Am Pharm Assoc (2003); 2020; 60(6):e100-e104. PubMed ID: 32741598
[TBL] [Abstract][Full Text] [Related]
10. Pharmacoepidemiological Research on N-Nitrosodimethylamine-Contaminated Ranitidine Use and Long-Term Cancer Risk: A Population-Based Longitudinal Cohort Study.
Wang CH; Chen II; Chen CH; Tseng YT
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231768
[TBL] [Abstract][Full Text] [Related]
11. NDMA impurity in valsartan and other pharmaceutical products: Analytical methods for the determination of N-nitrosamines.
Parr MK; Joseph JF
J Pharm Biomed Anal; 2019 Feb; 164():536-549. PubMed ID: 30458387
[TBL] [Abstract][Full Text] [Related]
12. The contamination of valsartan and other sartans, part 1: New findings.
Sörgel F; Kinzig M; Abdel-Tawab M; Bidmon C; Schreiber A; Ermel S; Wohlfart J; Besa A; Scherf-Clavel O; Holzgrabe U
J Pharm Biomed Anal; 2019 Aug; 172():395-405. PubMed ID: 31122801
[TBL] [Abstract][Full Text] [Related]
13. Association between ranitidine use with potential NDMA impurities and risk of cancer in Korea.
Joung KI; Hwang JE; Oh IS; Cho SI; Shin JY
Sci Rep; 2022 Dec; 12(1):22396. PubMed ID: 36575247
[TBL] [Abstract][Full Text] [Related]
14. [Valsartan contamination].
Jilesen DPMW; Kramers C; Kerkvliet CTM; Bosch FH
Ned Tijdschr Geneeskd; 2019 Mar; 163():. PubMed ID: 30945826
[TBL] [Abstract][Full Text] [Related]
15. Lesson Learnt from Recall of Valsartan and Other Angiotensin II Receptor Blocker Drugs Containing NDMA and NDEA Impurities.
Charoo NA; Ali AA; Buha SK; Rahman Z
AAPS PharmSciTech; 2019 Apr; 20(5):166. PubMed ID: 30989447
[TBL] [Abstract][Full Text] [Related]
16. Implications of an epidemiological study showing an association between in utero NDMA exposure and childhood cancer.
Engelward BP
Environ Mol Mutagen; 2021 Jun; 62(5):288-292. PubMed ID: 33963777
[TBL] [Abstract][Full Text] [Related]
17. Risk of Cancer Following the Use of N-Nitrosodimethylamine (NDMA) Contaminated Ranitidine Products: A Nationwide Cohort Study in South Korea.
Yoon HJ; Kim JH; Seo GH; Park H
J Clin Med; 2021 Jan; 10(1):. PubMed ID: 33466237
[TBL] [Abstract][Full Text] [Related]
18. HS-SPME-GC-MS as an alternative method for NDMA analysis in ranitidine products.
Alshehri YM; Alghamdi TS; Aldawsari FS
J Pharm Biomed Anal; 2020 Nov; 191():113582. PubMed ID: 32889348
[TBL] [Abstract][Full Text] [Related]
19. Neoplasm Reports in Food and Drug Administration Adverse Event Reporting System Following Angiotensin Receptor Blocker Recalls.
Cohen Sedgh R; Moon J; Jackevicius CA
Circ Cardiovasc Qual Outcomes; 2021 Aug; 14(8):e007476. PubMed ID: 34380327
[TBL] [Abstract][Full Text] [Related]
20. Application of capillary electrophoresis-nano-electrospray ionization-mass spectrometry for the determination of N-nitrosodimethylamine in pharmaceuticals.
Řemínek R; Foret F; Chung DS
Electrophoresis; 2021 Feb; 42(4):334-341. PubMed ID: 33368407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
